Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Bone hydroxyapatite (HAP) is the primary mineral component of bone, responsible for its rigidity and mechanical strength. It is a naturally occurring form of calcium phosphate with the chemical formula Ca₁₀(PO₄)₆(OH)₂. HAP provides bones with compressive strength and supports osseointegration. It is a target for drugs like bisphosphonates and can be utilized for targeted drug delivery to bone tissue.
Bisphosphonates bind to hydroxyapatite and inhibit osteoclast activity. Phytate binds to growth sites on hydroxyapatite crystals, inhibiting calcification.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bone Hydroxyapatite Crystal (HAP).